B7438
6-B345TTQ
>98% (HPLC)
别名:
6-Bromo-3,4-dihydro-4-(3,4,5-trimethoxyphenyl)-benzo[h]quinolin-2(1H)-one
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C22H20BrNO4
化学文摘社编号:
分子量:
442.30
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
产品名称
6-B345TTQ, >98% (HPLC)
InChI key
KPOXOTVERMGJQS-UHFFFAOYSA-N
SMILES string
COc1cc(cc(OC)c1OC)C2CC(=O)Nc3c2cc(Br)c4ccccc34
InChI
1S/C22H20BrNO4/c1-26-18-8-12(9-19(27-2)22(18)28-3)15-11-20(25)24-21-14-7-5-4-6-13(14)17(23)10-16(15)21/h4-10,15H,11H2,1-3H3,(H,24,25)
assay
>98% (HPLC)
form
powder
color
white to off-white
solubility
DMSO: ≥20 mg/mL
storage temp.
2-8°C
Quality Level
Biochem/physiol Actions
6-B345TTQ is a non-cytotoxic inhibitor of α4 integrin paxillin interaction.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Jordan J Toutounchian et al.
Molecular pharmacology, 91(1), 1-13 (2016-12-04)
Targeting vascular endothelial growth factor (VEGF) is a common treatment strategy for neovascular eye disease, a major cause of vision loss in diabetic retinopathy and age-related macular degeneration. However, the decline in clinical efficacy over time in many patients suggests
Daniela Alfano et al.
Human molecular genetics, 28(14), 2295-2308 (2019-06-11)
Tbx1, the major candidate gene for DiGeorge or 22q11.2 deletion syndrome, is required for efficient incorporation of cardiac progenitors of the second heart field (SHF) into the heart. However, the mechanisms by which TBX1 regulates this process are still unclear.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持